Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208758
Max Phase: Preclinical
Molecular Formula: C37H57N2O10P
Molecular Weight: 720.84
Associated Items:
ID: ALA5208758
Max Phase: Preclinical
Molecular Formula: C37H57N2O10P
Molecular Weight: 720.84
Associated Items:
Canonical SMILES: CCCCCCCCCCCOc1cccc(CCC(=O)NC[C@@H](O)COP(=O)(O)OC[C@H](NC(=O)c2ccc(C(C)(C)C)cc2)C(=O)O)c1
Standard InChI: InChI=1S/C37H57N2O10P/c1-5-6-7-8-9-10-11-12-13-23-47-32-16-14-15-28(24-32)17-22-34(41)38-25-31(40)26-48-50(45,46)49-27-33(36(43)44)39-35(42)29-18-20-30(21-19-29)37(2,3)4/h14-16,18-21,24,31,33,40H,5-13,17,22-23,25-27H2,1-4H3,(H,38,41)(H,39,42)(H,43,44)(H,45,46)/t31-,33+/m1/s1
Standard InChI Key: RRHDWKLYSYYYCK-VTIYRKAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 720.84 | Molecular Weight (Monoisotopic): 720.3751 | AlogP: 6.32 | #Rotatable Bonds: 25 |
Polar Surface Area: 180.72 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.88 | CX Basic pKa: | CX LogP: 6.80 | CX LogD: 1.01 |
Aromatic Rings: 2 | Heavy Atoms: 50 | QED Weighted: 0.06 | Np Likeness Score: -0.26 |
1. Sayama M, Uwamizu A, Ikubo M, Chen L, Yan G, Otani Y, Inoue A, Aoki J, Ohwada T.. (2021) Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine., 64 (14.0): [PMID:34233115] [10.1021/acs.jmedchem.1c00347] |
Source(1):